Dim3
Last board
2 directors, 1 in day-to-day management, last change in 2024Director and managing director, permanent representative Arnaud Lallemand
director in office according to the deed of 14-07-2022
managing director appointed by deed of 21-10-2022
also on the board of 3 other companies
- ALTCare SRL
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Article 21: Représentation Sans préjudice des pouvoirs du délégué à la gestion journalière, en ce qui concerne cette gestion, la société est…”deed of 09-09-2019
Permanent representatives 1
Arnaud Lallemand
Permanent representative, for ALTCare SRL
in office according to the deed of 14-07-2022
Mandates through the years
13 names, the dashed line is todayALTCare SRL
Director, Daily management delegate
Director, Daily management delegate
REYNAERT Coralie
Chair, Secretary
Chair, Secretary
ALSTEENS Yannick
Liquidator
Liquidator
Jean-Claude Havaux
Director
Director
Newton Biocapital Partners SPRL
Director
Director
Renaud Mazy
Director
Director
Sparaxis SA
Director
Director
Victor Invest SRL
Director
Director
Béatrice Alié
Director
Director
GEMA SRL
Director
Director
Guy Heyen
Director
Director
Els Hubloux
Director
Director
AQ Invest
Director
Director
LeadershipBoardOther functionEarliermandate already running before its first mentionend not dated
Mandates as a list
- ALTCare SRL
- Director, from 17-06-2022 to date
- Daily management delegate, appointed by deed of 21-10-2022, still in office
- REYNAERT Coralie
- Secretary, appointed by deed of 02-10-2024, still in office
- Chair, appointed by deed of 02-10-2024, still in office
- ALSTEENS Yannick
- Liquidator, appointed by deed of 02-10-2024, still in office
- Jean-Claude Havaux
- Director, from 17-07-2017, no longer listed in the 2025 annual accounts
- Daily management delegate, until 21-10-2022
- Newton Biocapital Partners SPRL
- Director, appointed by deed of 25-09-2019, no longer listed in the 2025 annual accounts
- Renaud Mazy
- Director, from 17-07-2017, no longer listed in the 2025 annual accounts
- Sparaxis SA
- Director, from 17-06-2022, no longer listed in the 2025 annual accounts
- Victor Invest SRL
- Director, from 17-07-2017, no longer listed in the 2025 annual accounts
- Béatrice Alié
- Director, from 17-06-2022, no longer listed in the 2025 annual accounts
- GEMA SRL
- Director, from 17-07-2017 to 22-06-2022
- Guy Heyen
- Director, until 22-06-2022
- Els Hubloux
- Director, appointed by deed of 25-09-2019, until 19-02-2019
- AQ Invest
- Director, until 27-07-2018
Control
Shareholder
Equity €59.5m
Loss €5.3m in 2025 (loss €18.7m in 2024)
Checked score 92
53,523 voting rights
36.19%
This company
Dim3
Equity -€463,262
Loss €10,332 in 2025
Free float 9.73%
Capital
- Capital
- €8,599,474.54
- Shares
- 187,368
- Contribution per share
- €45.90
- Equity per share
- -€2.47 in 2025
- Source
- deed of 14-07-2020 and 7 later capital increases
Owners through the years
as the annual accounts name themOwners as a list
- Newton Biocapital I, pricaf privée de droit belge
- Wallonie Entreprendre
- VICTOR INVEST
- JCHYTECH
- NOSHAQ
- NOSHAQ SPIN-OFFS
- LEANSQUARE
- FIPAS
- SOCIETE WALLONNE DE GESTION ET DE PARTICIPATIONS
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE
- STRIGO
Older annual accounts also name 1 natural person.
Source: shareholder structure in its own accounts, lists of holdings in the owners' accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 22-06-2022 (in French)
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 6 directorsAt most 7 directors“6 ans”deed of 14-07-2022 (in French)
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- “Mêmes droits et avantages sauf dispositions contraires des statuts ou de la Convention”deed of 15-04-2024 (in French)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Second Monday of June at 18:00deed of 22-06-2022 (in French)
Shareholders
4 ownersOwners 5
- Equity €59.5m Loss of €5.3m in 2025 (loss of €18.7m in 2024) Checked score 9236.19%
- Equity -€3.6m Loss of €2.6m in 2025 (loss of €2.1m in 2024) Checked score 4725.28%
- Equity €4.98bn Profit of €151.2m in 2025 (profit of €279.8m in 2024)20.83%
- Other shareholdersfree floatSourceown accounts 20239.73%
-
5.38%
Capital transactions
Capital over time
- 26-09-2024 Capital stated in the deed · 187,368 shares
- 15-04-2024 Capital increase of €749,970 · 9,615 new shares at €78 per share · in cash
- 15-04-2024 Capital increase of €1,383,650 · 22,172 new shares at €62.40 per share · in kind
- 14-07-2022 Capital increase of €499,970 · 29,410 new shares · in cash
- 14-07-2022 Capital increase of €303,250 · 17,838 new shares · in kind
- 22-06-2022 Capital increase of €392,312.50 · 23,075 new shares at €17 per share · in kind
- 22-06-2022 Capital increase of €120,003 · 7,059 new shares at €17 per share · in kind
- 22-06-2022 Capital increase of €500,004 · 29,412 new shares · in cash
Show 5 older capital entries
- 14-07-2020 Capital increase of €699,972 · to €4,650,315.04 · 4,487 new shares, 9.2% of the 48,787 shares after the increase · in cash
- 18-03-2020 Capital increase of €650,052 · to €3,950,343.04 · 4,167 new shares, 9.4% of the 44,300 shares after the increase · in cash
- 17-02-2020 Capital reduction of €1,939,777 · to €3,300,291.04 · to absorb losses
- 25-11-2019 Capital increase of €0.04 · 11,218 new shares · “exercice de 4 Warrants Anti-dilution”
- 09-09-2019 Capital increase of €650,052 · to €5,240,068 · 4,167 new shares, 14.4% of the 28,915 shares after the increase · virement